Organigram Global Inc. Files 6-K, Opts for Form 40-F

Ticker: OGI · Form: 6-K · Filed: Oct 29, 2025 · CIK: 1620737

Sentiment: neutral

Topics: reporting, sec-filing, foreign-private-issuer

TL;DR

Organigram Global Inc. filed a 6-K, confirming they'll use Form 40-F for their annual report.

AI Summary

Organigram Global Inc. filed a Form 6-K on October 29, 2025, indicating it will file its annual report under cover of Form 40-F. The company, formerly Organigram Holdings Inc., is based in Toronto, Ontario, Canada, and operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing signals Organigram's adherence to reporting requirements for foreign private issuers, specifically its intention to use Form 40-F for its annual report, which is common for Canadian companies listed in the U.S.

Risk Assessment

Risk Level: low — The filing is a routine procedural report and does not contain new financial or operational information that would typically impact risk.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers that is submitted to the SEC to provide information that the issuer either has made or will make public in its home country, or has submitted or will submit to its home country's securities commission.

What is Form 40-F?

Form 40-F is an annual report required by the SEC for certain Canadian issuers, serving as a simplified annual report that allows them to use their home country filings.

When was Organigram Global Inc. formerly known as Organigram Holdings Inc.?

The company was formerly known as Organigram Holdings Inc. with a date of name change on August 31, 2016, and also on September 26, 2014.

Where are Organigram Global Inc.'s principal executive offices located?

The principal executive offices of Organigram Global Inc. are located at 145 King Street West, Suite 1400, Toronto, Ontario, Canada.

What is the SIC code for Organigram Global Inc.?

The Standard Industrial Classification (SIC) code for Organigram Global Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 189 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2025-10-29 15:21:10

Filing Documents

From the Filing

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F X Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) SUBMITTED HEREWITH Exhibits 99.1 Press release dated October 29, 2025 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ORGANIGRAM GLOBAL INC. s Greg Guyatt Greg Guyatt Chief Financial Officer Date October 29, 2025

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing